Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double vs Single Dose Tamsulosin and Solifenacin for Stent Symptoms
NCT06955533Completed
- Sponsor
- Ain Shams University
- Start
- Apr 2024
- Primary completion
- Aug 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of tamsulosin and solifenacin in ureteral stent syndrome (SRS) (2 arms), sponsored by Ain Shams University. Primary endpoint: Ureteral Stent Symptom Questionnaire at 2 weeks. Started Apr 2024; status: completed.
02
Drugs
tamsulosinsolifenacin
03
Conditions
ureteral stent syndrome (SRS)
Beyond the preview
Go deeper on NCT06955533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06955533.